Acerus to Report First Quarter 2019 Financial Results and Host Investor Call

TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP) will announce its first
quarter 2019 financial and operating results on Monday May 13, 2019
before the market opens. The company will host a conference call on
Monday, May 13, 2019 at 8:30 a.m. Eastern Time.

To access the call live, please dial 647-484-0475 or 1-888-882-4478.
Listeners are encouraged to dial in 10 minutes before the call begins to
avoid delays. A replay of the conference call will be available until
11:59 p.m. Eastern Time on Tuesday, May 21, 2019 by dialing 905-694-9451
or 1-800-408-3053, using access code: 7327615#.

About Acerus

Acerus Pharmaceuticals Corporation is a Canadian-based specialty
pharmaceutical company focused on the development, manufacture,
marketing and distribution of innovative, branded products that improve
patient experience, with a primary focus in the field of men’s and
women’s health. The Company commercializes its products via its own
salesforce in Canada, and through a global network of licensed
distributors in the U.S. and other territories.

Acerus’ shares trade on TSX under the symbol ASP. For more information,
visit www.aceruspharma.com
and follow us on Twitter
and LinkedIn.

Contacts

Robert Motz
Chief Financial Officer
[email protected]
(905)
817-8288